CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 9, 2022 · earnings

MIRM earnings: a negative outcome, -16.4%

On November 9, 2022, Mirum Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -16.4% in the window around the event. It had already run +26.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$23.94
1d before
$20.02
Event day
$20.06
1d after
$19.23
5d after

Pre-catalyst setup

+26.2%
30-day run-up
8460%
30-day volatility
0.5×
volume spike